Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

14. Octobre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3092


	Articles 1 - 20 / 61827

	Pancreatic Adenocarcinoma, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw Ko AH, Malafa MP, Aguilera T, Basturk O, Benson AB 3rd, Cardin DB, Chiorean EG, Christensen JA, Chung V, Czito B, Chiaro MD, Dillhoff M, Donahue TR, Fountzilas C, Hardacre J, Klute K, Kunstman JW, Lim KH, LoConte N, Lowy AM, Masood A, Moravek C, Nakakura EK, Narang AK, Nardo L, Obando J, Polanco PM, Poultsides G, Reddy S, Reyngold M, Scaife C, Shergill A, Singh H, Truty MJ, Vollmer C Jr, Weinberg D, Wolff RA, Wolpin BM, McCullough B, Roth SL, Ramakrishnan S. PMID: 42869082 [PubMed - indexed for MEDLINE]
	Value of tumor burden score combined with alpha-fetoprotein stratification in transarterial chemoembolization plus tyrosine kinase inhibitors and immune checkpoint inhibitors as triple conversion therapy for patients with initially unresectable hepatocellular carcinoma: a multicenter retrospective study (GUIDANCE010). Eur J Surg Oncol Li ZC, Li CH, Yang DL, Su JY, Liu SP, Ye L, Peng N, Zeng FJ, Li MJ, Liang YR, Chen SC, Yang FQ, Wang XY, Qin C, Zhong TM, Mao XS, Su Z, Dong XF, Yang J, Xu B, Su H, Han RX, Qin ZL, Mo BY, Huang HG, Zhong JH, GUIDANCE investigators. PMID: 42868946 [PubMed - as supplied by publisher]
	Toward Clinically Actionable Prediction of Recurrence and Metastatic Progression in Pancreatic Ductal Adenocarcinoma: A Systematic Review. JCO Clin Cancer Inform Gong L, Chang C, Agyekum A, Aswani N, Yang JY, Shahinnian P, Manji G, Kang SK, Hur C. PMID: 42868319 [PubMed - indexed for MEDLINE]
	MRI for restaging pancreatic cancer. Insights Imaging Zamboni GA, Omboni F, Panozzo I. PMID: 42867719 [PubMed]
	Cumulative obesity exposure and hepato-pancreato-biliary cancer risk following different weight-loss interventions: retrospective cohort study. Ann Med Surg (Lond) Kukeev I, Arnon Y, Quint E, Freih SA, Osyntsov A, Dukhno O. PMID: 42866765 [PubMed]
	Pancreatic Tuberculosis Mimicking Pancreatic Cancer in a Young Immunocompetent Man: A Case Report and Literature Review. Int Med Case Rep J Kazemi K, Soleimani N, Jafari M, Pouraminaee F, Dehghani Z, Mohammadzadeh S, Dehbanizadeh S. PMID: 42866548 [PubMed - indexed for MEDLINE]
	Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation. Front Oncol Xu H, Yi J, Zhang W, Zhu S, Liu Z. PMID: 42865793 [PubMed]
	Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis. Front Oncol Hu C, Zhan L, Li Y, Ren X, Yu Z. PMID: 42865438 [PubMed]
	Recent advances in systemic therapy for biliary tract cancer: Evidence from Japan and recommendations in guidelines. Proc Jpn Acad Ser B Phys Biol Sci Okusaka T, Furuse J, Konishi M, Ohtsuka M. PMID: 42864016 [PubMed - indexed for MEDLINE]
	Novel Tool to Predict Primary Tumor Location in the Setting of Metastatic Cancer With Unknown Primary. JCO Oncol Pract Eldeeb K, Badat S, Perlow HK, Baydoun A, Vempati P, Yang Y, Spratt DE, Wang M, Zaorsky NG. PMID: 42863101 [PubMed - as supplied by publisher]
	Clinical Efficacy of Tislelizumab Plus Gemcitabine-Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer and Chemoresistance Analysis: A Prospective Pilot Study. Ann Surg Oncol He Y, Peng X, Jiang C, Li J, Li S, Xiang X, You N, Yang X, Tang Y, Huang X, Zheng L. PMID: 42862523 [PubMed - as supplied by publisher]
	ZnO-Pd nanobolts-based immunoanalytical detection of a pancreatic cancer biomarker and its software-assisted digital quantification. Nanoscale Horiz Deshwal A, Rajesh, Chung SJ, Mishra P, Tripathi RM. PMID: 42861634 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Localized Pancreatic Cancer: Trans-Atlantic Pancreatic Surgery Consortium Study. Ann Surg Oncol Okui J, Besselink MG, Wei AC, O'Reilly EM, Koerkamp BG, Ceuppens S, Dekker EN, Paniccia A, Zureikat AH, Tzeng CD, Katz MHG, Ikoma N, the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. PMID: 42860496 [PubMed - as supplied by publisher]
	Protocol for an immunocompetent KPC mouse model of pancreatic cancer resection and recurrence for perioperative treatment studies. STAR Protoc Léger JL, Amhis N, Mansouri S, Pacheco MFM, Daniel L, Giguère H, Collin Y, Tai LH. PMID: 42858257 [PubMed - as supplied by publisher]
	Molecular Profiling in Mucinous Pancreatic Cystic Neoplasms: Implications for Surgical Decision-Making - A Narrative Review. J Vis Exp Gao R, Gao Y, Jiao Y, Liu YH. PMID: 42858026 [PubMed - indexed for MEDLINE]
	Research progress of pancreatic cancer based on ferroptosis-cuproptosis interaction (Review). Oncol Lett Liu W, Ding M, Ji R, Qiao Z, Liu R, Chen P, Liu L. PMID: 42857319 [PubMed]
	Ginsenoside Rb1 From the Functional Food Panax ginseng Suppresses Pancreatic Cancer Progression via Macrophage Reprogramming Through the PI3K-AKT Pathway. Food Sci Nutr Dong CS, Wang G, Niu Y, Sun X, Ren W, Zhang J, Zhang Y, Wu RX, Wu X. PMID: 42857277 [PubMed]
	Clinical diagnostic value of serum CEA and CA19-9 in patients with advanced pancreatic cancer: A prognostic cohort study. Front Oncol Song J, Kang F, Ma L, Zhang A, Yang F, Liu Q. PMID: 42856853 [PubMed]
	Development of a predictive model for pancreatic cancer integrating serum metabolomics and polygenic risk score. Front Endocrinol (Lausanne) Wang X, Yang H, Li J, Wang X, Tong L, Han Z, Li Y, Liu M, Guo L, Zhou S, Ran Y, Zhao J, Zhou L. PMID: 42856819 [PubMed - indexed for MEDLINE]
	Cancer degronopathies and protein-fate biomarkers in drug resistance and cancer progression: signalling mechanisms, measurement and translational limits. Front Cell Dev Biol Li J, Liu S, Fu L, Bo Q, Bai Y, Dai X. PMID: 42856810 [PubMed]

Articles 1 - 20 / 61827

Page 1 de 3092



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité